[go: up one dir, main page]

WO2001066738A3 - Acides nucleiques codant des polypeptides crsp1 humains et utilisations de ces derniers - Google Patents

Acides nucleiques codant des polypeptides crsp1 humains et utilisations de ces derniers Download PDF

Info

Publication number
WO2001066738A3
WO2001066738A3 PCT/US2001/003685 US0103685W WO0166738A3 WO 2001066738 A3 WO2001066738 A3 WO 2001066738A3 US 0103685 W US0103685 W US 0103685W WO 0166738 A3 WO0166738 A3 WO 0166738A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acids
crsp1
hcrsp1
encoding human
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/003685
Other languages
English (en)
Other versions
WO2001066738A2 (fr
Inventor
Eric Wen Su
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Priority to AU2001239742A priority Critical patent/AU2001239742A1/en
Publication of WO2001066738A2 publication Critical patent/WO2001066738A2/fr
Publication of WO2001066738A3 publication Critical patent/WO2001066738A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne au moins un nouveau polypeptide hCRSP1 et des acides nucléiques isolés qui codent ce ou ces polypeptides hCRSP1, des polypeptides hCRSP1, des vecteurs, des cellules hôtes, des produits transgéniques, des chimères et des procédés de préparation et d'utilisation de ces derniers ainsi que des anticorps à spécificité hCRSP1 et des procédés associés.
PCT/US2001/003685 2000-03-06 2001-02-21 Acides nucleiques codant des polypeptides crsp1 humains et utilisations de ces derniers Ceased WO2001066738A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001239742A AU2001239742A1 (en) 2000-03-06 2001-02-21 Nucleic acids, encoding human crsp1 and uses thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18711700P 2000-03-06 2000-03-06
US60/187,117 2000-03-06

Publications (2)

Publication Number Publication Date
WO2001066738A2 WO2001066738A2 (fr) 2001-09-13
WO2001066738A3 true WO2001066738A3 (fr) 2002-03-07

Family

ID=22687664

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/003685 Ceased WO2001066738A2 (fr) 2000-03-06 2001-02-21 Acides nucleiques codant des polypeptides crsp1 humains et utilisations de ces derniers

Country Status (2)

Country Link
AU (1) AU2001239742A1 (fr)
WO (1) WO2001066738A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060210974A1 (en) * 2002-06-13 2006-09-21 Metabolex, Inc. Compositions and methods for preventing, treating and diagnosing diabetes

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000069885A2 (fr) * 1999-05-14 2000-11-23 Millennium Pharmaceuticals, Inc. Proteines secretees et leur utilisation
WO2001004264A2 (fr) * 1999-07-07 2001-01-18 Incyte Genomics, Inc. Genes associes a l'atherosclerose

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000069885A2 (fr) * 1999-05-14 2000-11-23 Millennium Pharmaceuticals, Inc. Proteines secretees et leur utilisation
WO2001004264A2 (fr) * 1999-07-07 2001-01-18 Incyte Genomics, Inc. Genes associes a l'atherosclerose

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL 12 March 1999 (1999-03-12), K. KOEHRER ET AL: "Homo spiens mRNA; EST DKFZp434G036_r1 (from clone DKFZp434G036)", XP002179373 *
DATABASE EMBL 18 April 1997 (1997-04-18), M.D. ADAMS ET AL: "EST22669 Adipose tissue, white II Homo sapiens cDNA 5' end similar to osteonectin", XP002179372 *
DATABASE EMBL 27 September 2000 (2000-09-27), P. MAURER: "Mus musculus mRNA for secreted modular calcium-binding protein 2 (SMOC2 gene)", XP002179376 *
DATABASE EMBL 4 June 1995 (1995-06-04), L. HILLIER ET AL: "The WashU- MERck EST project. yi30a08.r1 Soares placenta Nb2HP Homo sapiens cDNA clone IMAGE:140726 5' similar to contaoins TAR1 repetitive element; mRNA sequence", XP002179374 *
DATABASE EMBL 8 January 2001 (2001-01-08), S. NISHIMOTO ET AL: "Homo sapiens mRNA for SMAP-2, complete sds", XP002179375 *
M.D. ADAMS ET AL: "Initial assessment of human gene diversity and expression patterns based upon 83 millions basepairs of cDNA sequence", NATURE, vol. 377, 1995, pages 3 - 174 *
UNPUBLISHED *
YAN QI ET AL: "SPARC, a matricellular glycoprotein with important biological functions.", JOURNAL OF HISTOCHEMISTRY AND CYTOCHEMISTRY, vol. 47, no. 12, December 1999 (1999-12-01), pages 1495 - 1505, XP001024996, ISSN: 0022-1554 *

Also Published As

Publication number Publication date
AU2001239742A1 (en) 2001-09-17
WO2001066738A2 (fr) 2001-09-13

Similar Documents

Publication Publication Date Title
WO2004003147A3 (fr) Polypeptides cngh0004, anticorps, compositions, procedes et utilisations
WO1999061469A3 (fr) Proteines de membrane associees a la croissance de la prostate
WO2003089598A3 (fr) Polypeptides a activite xyloglucanase, et acides nucleiques codant ceux-ci
WO2001046420A3 (fr) Polypeptides homologues de l'il-17 et leurs utilisations therapeutiques
WO2002062999A8 (fr) Proteines et acides nucleiques codant pour celles-ci
WO2002059315A3 (fr) Nouveaux acides nucleiques et polypeptides et procedes de leur utilisation
WO2002046409A3 (fr) Proteines et acides nucleiques les codant
WO2003038041A3 (fr) Mut-il-4: proteines, anticorps, compositions, procedes et utilisations
WO2002081517A3 (fr) Nouveaux polypeptides et acides nucleiques codant pour ces derniers
WO2002066647A3 (fr) Recepteur de cytokine de type 2 et acides nucleiques codant ce recepteur
WO2001090326A3 (fr) Nouvelles metalloproteinases matricielles
WO2000059942A3 (fr) COMPOSITIONS hOB-BP2h, LEURS TECHNIQUES ET LEURS UTILISATIONS
WO2002016611A3 (fr) Polypeptides d'interleukine-22, acides nucleiques codant pour lesdits polypeptides et methode permettant de traiter les affections pancreatiques
WO2001085961A3 (fr) Matieres a base de caspase 12 humaine et methodes de production et d'utilisation
WO2002002771A3 (fr) Nouveau gene hsparc-11 et procedes de fabrication et d'utilisation de ce dernier
WO2003102017A3 (fr) Anticorps diriges contre la fusion de la proteine de type reg, compositions, procedes et utilisations
WO2002085922A3 (fr) Proteines et acides nucleiques codant pour celles-ci
WO2000039297A3 (fr) Polypeptides apparentes a il-1
WO2001083552A3 (fr) Acides nucleiques et polypeptides sez6 humains
WO2002090500A3 (fr) Nouvelles proteines humaines, polynucleotides codant ces proteines et methodes d'utilisation des proteines
WO2001066738A3 (fr) Acides nucleiques codant des polypeptides crsp1 humains et utilisations de ces derniers
WO2002059345A3 (fr) Acide nucleique codant un composant proteique transporteur d'ions
WO2002046408A3 (fr) Nouvelles proteines humaines, polynucleotides les codant et procedes d'utilisation
WO2002048187A3 (fr) Peptides du signal de secretion, leurs sequences adn, vecteurs d'expression pour cellules eucaryotes preparees a partir de ceux-ci, et leur utilisation pour la preparation biotechnologique de proteines
WO2001000662A3 (fr) Utilisation de polypeptides fgh-8 humains comme agents neurotrophiques

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP